TARO-CLOTRIMAZOLE/BETAMETHASONE DIPROPIONATE

Google image searchProduct monograph

Active ingredients

betamethasone (betamethasone dipropionate), 0.05 %/W/W

clotrimazole, 1 %/W/W

DIN: 02496410

Dosage form(s): CREAM

Route(s) of administration: TOPICAL

Schedule: Prescription

Company: TARO PHARMACEUTICALS INC

Date: 06-APR-2020

ATC:

• D01 — ANTIFUNGALS FOR DERMATOLOGICAL USE (ATC, ATC/DDD, )
• D01A — ANTIFUNGALS FOR TOPICAL USE (ATC, ATC/DDD)
• D01AC — Imidazole and triazole derivatives (ATC, ATC/DDD)
• D01AC20 — IMIDAZOLES/TRIAZOLES IN COMBINATION WITH CORTICOSTEROIDS (ATC/DDD)

Pharmaceutical standard: USP

External Links for Taro-Clotrimazole/Betamethasone Dipropionate

Search on Google

• Taro-Clotrimazole/Betamethasone Dipropionate side effects
• Taro-Clotrimazole/Betamethasone Dipropionate dosage
• betamethasone side effects
• betamethasone dosage
• clotrimazole side effects
• clotrimazole dosage

Taro Pharmaceuticals Inc

Go to Taro website to see drug product details. Sometimes you can find taro-clotrimazole/betamethasone dipropionate photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.